MORGAN STANLEY PLC/CALL/STRYKER CORP./280/0.1/21.06.24 Stock

Warrant

DE000MD9T581

Delayed Börse Stuttgart 04:14:44 2024-06-17 EDT
6.02 EUR +1.35% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./280/0.1/21.06.24
Current month+6.64%
1 month+37.18%
Date Price Change
24-06-17 6.02 +1.35%
24-06-14 5.94 -0.67%
24-06-13 5.98 -2.92%
24-06-12 6.16 -1.12%
24-06-11 6.23 -1.27%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 04:14 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MD9T58
ISINDE000MD9T581
Date issued 2022-10-26
Strike 280 $
Maturity 2024-06-21 (4 Days)
Parity 10 : 1
Emission price 2.36
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 7.75
Lowest since issue 1.45
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.232
Difference Strike -63.53 $
Difference Strike %-22.69%
Intrinsic value 6.063

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus